Exact Mass: 650.4506

Arjunolic acid 3-glucoside

C36H58O10 (650.403)

Arjunolic acid 3-glucoside is found in fruits. Arjunolic acid 3-glucoside is a constituent of Luffa cylindrica (smooth luffa). Constituent of Luffa cylindrica (smooth luffa). Arjunolic acid 3-glucoside is found in fruits.

Lucyoside N

C36H58O10 (650.403)

Lucyoside N is found in fruits. Lucyoside N is a constituent of Luffa cylindrica (smooth luffa). Constituent of Luffa cylindrica (smooth luffa). Lucyoside N is found in fruits.

Saponin H

C36H58O10 (650.403)

Saponin H is a constituent of Hovenia dulcis (raisin tree) Constituent of Hovenia dulcis (raisin tree)

Pedunculoside

C36H58O10 (650.403)

PA(12:0/18:1(12Z)-2OH(9,10))

C33H63O10P (650.4159)

PA(12:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(12:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one dodecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/12:0)

C33H63O10P (650.4159)

PA(18:1(12Z)-2OH(9,10)/12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/12:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of dodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(i-12:0/18:1(12Z)-2OH(9,10))

C33H63O10P (650.4159)

PA(i-12:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-12:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/i-12:0)

C33H63O10P (650.4159)

PA(18:1(12Z)-2OH(9,10)/i-12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/i-12:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

DG(15:0/PGE2/0:0)

C38H66O8 (650.4757)

DG(15:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/15:0/0:0)

C38H66O8 (650.4757)

DG(PGE2/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/PGE2)

C38H66O8 (650.4757)

DG(15:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/15:0)

C38H66O8 (650.4757)

DG(PGE2/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/PGD2/0:0)

C38H66O8 (650.4757)

DG(15:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/15:0/0:0)

C38H66O8 (650.4757)

DG(PGD2/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/PGD2)

C38H66O8 (650.4757)

DG(15:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/15:0)

C38H66O8 (650.4757)

DG(PGD2/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C38H66O8 (650.4757)

DG(15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/15:0/0:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C38H66O8 (650.4757)

DG(15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/15:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/PGE2/0:0)

C38H66O8 (650.4757)

DG(a-15:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/a-15:0/0:0)

C38H66O8 (650.4757)

DG(PGE2/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/PGE2)

C38H66O8 (650.4757)

DG(a-15:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/a-15:0)

C38H66O8 (650.4757)

DG(PGE2/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/PGD2/0:0)

C38H66O8 (650.4757)

DG(a-15:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/a-15:0/0:0)

C38H66O8 (650.4757)

DG(PGD2/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/PGD2)

C38H66O8 (650.4757)

DG(a-15:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/a-15:0)

C38H66O8 (650.4757)

DG(PGD2/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C38H66O8 (650.4757)

DG(a-15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-15:0/0:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C38H66O8 (650.4757)

DG(a-15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-15:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/PGE2/0:0)

C38H66O8 (650.4757)

DG(i-15:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/i-15:0/0:0)

C38H66O8 (650.4757)

DG(PGE2/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/PGE2)

C38H66O8 (650.4757)

DG(i-15:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/i-15:0)

C38H66O8 (650.4757)

DG(PGE2/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/PGD2/0:0)

C38H66O8 (650.4757)

DG(i-15:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/i-15:0/0:0)

C38H66O8 (650.4757)

DG(PGD2/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/PGD2)

C38H66O8 (650.4757)

DG(i-15:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/i-15:0)

C38H66O8 (650.4757)

DG(PGD2/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C38H66O8 (650.4757)

DG(i-15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-15:0/0:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C38H66O8 (650.4757)

DG(i-15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-15:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Pedunculoside

C36H58O10 (650.403)

Pedunculoside is a natural product found in Ilex chinensis, Ilex excelsa, and other organisms with data available. Pedunculoside exerts lipid-lowering effects partly through the regulation of?lipogenesis?and?fatty acid β-oxidation[1]. Pedunculoside exerts lipid-lowering effects partly through the regulation of?lipogenesis?and?fatty acid β-oxidation[1]. Pedunculoside exerts lipid-lowering effects partly through the regulation of?lipogenesis?and?fatty acid β-oxidation[1].

Rosamultin

C36H58O10 (650.403)

Rosamultin is a 19 α-hydroxyursane-type triterpenoid isolated from Potentilla anserina?L. Rosamultin has inhibitory effects against HIV-1 protease[1]. Rosamultin has the potential for treating H2O2-induced oxidative stress injury through its antioxidant and antiapoptosis effects[2]. Rosamultin is a 19 α-hydroxyursane-type triterpenoid isolated from Potentilla anserina?L. Rosamultin has inhibitory effects against HIV-1 protease[1]. Rosamultin has the potential for treating H2O2-induced oxidative stress injury through its antioxidant and antiapoptosis effects[2].

Bayogenin 3-O-β-D-glucopyranoside

C36H58O10 (650.403)

Bayogenin 3-O-beta-D-glucopyranoside is a natural product found in Dolichos kilimandscharicus, Polygala japonica, and Caryocar glabrum with data available.

Kajiichigoside F1

C36H58O10 (650.403)

kaji-ichigoside F1 is a natural product found in Sanguisorba officinalis, Photinia serratifolia, and other organisms with data available.

SCHEMBL14028927

C36H58O10 (650.403)

Kolokoside A

C36H58O10 (650.403)

MCULE-6340183574

C36H58O10 (650.403)

Kalidiumoside D

C36H58O10 (650.403)

Quadranoside I

C36H58O10 (650.403)

Sutherlandioside C

C36H58O10 (650.403)

Rubuside I

C36H58O10 (650.403)

Quadranoside X

C36H58O10 (650.403)

Kolokoside C

C36H58O10 (650.403)

Kolokoside D

C36H58O10 (650.403)

Arjunglucoside II

C36H58O10 (650.403)

spathodic acid 28-O-beta-glucopyranoside

C36H58O10 (650.403)

2alpha,3alpha,24-trihydroxyurs-12-en-28-oic acid-28-O-beta-D-glucopyranosyl ester|2??,3??,24-Trihydroxyurs-12-en-28-oic acid-28-O-??-D-glucopyranosyl ester

C36H58O10 (650.403)

Pictoside B

C36H58O10 (650.403)

2-(beta-D-glucopyranosyloxy)-3,16,20-trihydroxy-9-methyl-19-norlanosta-5,24-diene-22-one

C36H58O10 (650.403)

Arjunoside I

C36H58O10 (650.403)

3-O-beta-D-Glucopyranosyl-16beta-hydroxy-gratiogenine

C36H58O10 (650.403)

Anchusoside-4

C36H58O10 (650.403)

Mycoticin a

C36H58O10 (650.403)

gagunin M

C36H58O10 (650.403)

C44H58O4

C44H58O4 (650.4335)

12-O-beta-D-glucopyranoside of alnustic acid

C37H62O9 (650.4394)

21-O-??-D-Glucopyranosyl-3??,21??,30-trihydroxyolean-13(18)-en-24-oic acid

C36H58O10 (650.403)

C36H58O10

C36H58O10 (650.403)

3beta,6beta,16beta,21beta-tetrahydroxyolean-12-en-23-al 3-O-beta-glucopyranoside

C36H58O10 (650.403)

16-Deoxy,Me ester-Acacigenin B

C41H62O6 (650.4546)

3beta,21alpha,23-trihydroxyurs-12-en-28-oic acid 21-O-beta-D-glucopyranoside

C36H58O10 (650.403)

Aplydilactone

C40H58O7 (650.4182)

beta-D-glucopyranosyl 2alpha,3beta,6beta-trihydroxyolean-12-en-28-oate

C36H58O10 (650.403)

2alpha,3beta-dihydroxy-23-beta-D-glucopyranosyloxyolean-12-en-28-oic acid

C36H58O10 (650.403)

28-O-beta-D-glucopyranosyl-2alpha,3alpha,19-trihydoxy-18,19-secours-11,13(18)-dien-28-oic|kakisaponin C

C36H58O10 (650.403)

7-methoxycucurbita-5,24-dien-3beta,22xi,23xi-triol 23-O-beta-D-glucopyranoside|karaviloside IV

C37H62O9 (650.4394)

beta-sitosterol-3-(6-glyceryl)-D-glucopyranoside

C38H66O8 (650.4757)

huangqiyenin A

C36H58O10 (650.403)

3-O-beta-D-glucopyranosyl-olean-12-ene-3beta,27,28-triol-29-oic acid

C36H58O10 (650.403)

bafilomycin H

C37H62O9 (650.4394)

(23E)-(12R,20S)-12,20-dihydroxy-25-methoxy-3,4-secodammara-4(28),23-dien-3-oic acid 12-O-beta-D-quinovopyranoside|cyclocarioside D

C37H62O9 (650.4394)

(3b,7b,23E)-25-methoxycucurbita-5,23-diene-3,7,19-triol 7-beta-D-glucopyranoside

C37H62O9 (650.4394)

3-O-beta-D-glucopyranosyl-olean-12-ene-3beta,28,29-triol-27-oic acid

C36H58O10 (650.403)

(2alpha,3alpha,21beta)-21-(beta-D-glucopyranosyloxy)-2,3-dihydroxyolean-12-en-28-oic acid

C36H58O10 (650.403)

1beta,2alpha,3beta,19alpha-tetrahydroxyurs-12-ene-28-oate-3-O-beta-D-xylopyranoside

C36H58O10 (650.403)

Vicoside B

C36H58O10 (650.403)

Fritillebin A

C42H66O5 (650.491)

28-O-beta-D-glucopyranosyl-3alpha,19,24-trihydoxy-18,19-secours-11,13(18)-dien-28-oic|kakisaponin B

C36H58O10 (650.403)

(3beta,23E)-25-methoxycucurbita-5,23-dien-3-ol 7-O-beta-D-allopyranoside|balsaminoside A

C37H62O9 (650.4394)

29-O-beta-D-glucopyranosyl-3beta,23-dihydroxyolean-12-en-28-oic acid

C36H58O10 (650.403)

Suavissimoside F1

C36H58O10 (650.403)

Esculeoside A lacking O27 glucosyl residue

C36H58O10 (650.403)

Arjunetin

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,10S,11S,12aS,14bR)-10,11-dihydroxy-12a-(hydroxymethyl)-2,2,6a,6b,9,9-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate is a natural product found in Terminalia alata, Terminalia arjuna, and Potentilla erecta with data available. Arjunetin, isolated from Terminalia arjuna, is an insect feeding-deterrent and growth inhibitor[1]. Arjunetin, isolated from Terminalia arjuna, is an insect feeding-deterrent and growth inhibitor[1].

C36H58O10_beta-D-Glucopyranose, 1-O-[(2alpha,3beta,5xi,9xi,18xi)-2,3,19-trihydroxy-28-oxours-12-en-28-yl]

C36H58O10 (650.403)

C36H58O10_beta-D-Glucopyranose, 1-O-[(2alpha,3beta,5xi,9xi,18xi,19alpha)-2,3,19-trihydroxy-28-oxoolean-12-en-28-yl]

C36H58O10 (650.403)

C36H58O10_Hexopyranose, 1-O-(3,19,23-trihydroxy-28-oxours-12-en-28-yl)

C36H58O10 (650.403)

C36H58O10_1-O-[(2alpha,3beta,5xi,9xi,18xi)-2,3,23-Trihydroxy-28-oxoolean-12-en-28-yl]-beta-D-glucopyranose

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

Bayogenin base + O-Hex

C36H58O10 (650.403)

Annotation level-3

Thermoactinoamide_K

C34H62N6O6 (650.4731)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_major

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_42.7\\%

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_major

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_95.9\\%

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_16.2\\%

C36H58O10 (650.403)

HRLLL

C30H54N10O6 (650.4228)

DG(17:2/22:6/0:0)[iso2]

C42H66O5 (650.491)

PG(12:0/15:1(9Z))

C33H63O10P (650.4159)

PG(13:0/14:1(9Z))

C33H63O10P (650.4159)

PG(14:1(9Z)/13:0)

C33H63O10P (650.4159)

PG(15:1(9Z)/12:0)

C33H63O10P (650.4159)

PG(P-16:0/12:0)

C34H67O9P (650.4522)

Saponin H

C36H58O10 (650.403)

Arjunolic acid 3-glucoside

C36H58O10 (650.403)

Lucyoside N

C36H58O10 (650.403)

DG 39:8

C42H66O5 (650.491)

PG 27:1

C33H63O10P (650.4159)

PG O-28:1

C34H67O9P (650.4522)

Tetrabutylammonium perruthenate

C32H72N2O4Ru (650.4535)

3-((3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO)-&

C32H62N2O9S (650.4176)

D-Leucinamide, N-methyl-D-leucyl-D-valyl-D-phenylalanyl-D-phenylalanyl-

C36H54N6O5 (650.4155)

3beta,6beta,23-trihydroxyolean-12-en-28-oic acid 28-O-beta-D-glucopyranoside

C36H58O10 (650.403)

A triterpenoid saponin that is the monosaccharide derivative of (3beta,6beta)-3,6,23-trihydroxyolean-12-en-28-oic acid. It has been isolated from the stem bark of Kalopanax pictus.

quadranoside IV

C36H58O10 (650.403)

soyasapogenol A 3-O-beta-glucuronide

C36H58O10 (650.403)

A triterpenoid saponin that is the 3-O-beta-glucuronide of soyasapogenol A.

PA(12:0/18:1(12Z)-2OH(9,10))

C33H63O10P (650.4159)

PA(18:1(12Z)-2OH(9,10)/12:0)

C33H63O10P (650.4159)

PA(i-12:0/18:1(12Z)-2OH(9,10))

C33H63O10P (650.4159)

PA(18:1(12Z)-2OH(9,10)/i-12:0)

C33H63O10P (650.4159)

DG(15:0/PGE2/0:0)

C38H66O8 (650.4757)

DG(PGE2/15:0/0:0)

C38H66O8 (650.4757)

DG(15:0/0:0/PGE2)

C38H66O8 (650.4757)

DG(PGE2/0:0/15:0)

C38H66O8 (650.4757)

DG(15:0/PGD2/0:0)

C38H66O8 (650.4757)

DG(PGD2/15:0/0:0)

C38H66O8 (650.4757)

DG(15:0/0:0/PGD2)

C38H66O8 (650.4757)

DG(PGD2/0:0/15:0)

C38H66O8 (650.4757)

DG(a-15:0/PGE2/0:0)

C38H66O8 (650.4757)

DG(PGE2/a-15:0/0:0)

C38H66O8 (650.4757)

DG(a-15:0/0:0/PGE2)

C38H66O8 (650.4757)

DG(PGE2/0:0/a-15:0)

C38H66O8 (650.4757)

DG(a-15:0/PGD2/0:0)

C38H66O8 (650.4757)

DG(PGD2/a-15:0/0:0)

C38H66O8 (650.4757)

DG(a-15:0/0:0/PGD2)

C38H66O8 (650.4757)

DG(PGD2/0:0/a-15:0)

C38H66O8 (650.4757)

DG(i-15:0/PGE2/0:0)

C38H66O8 (650.4757)

DG(PGE2/i-15:0/0:0)

C38H66O8 (650.4757)

DG(i-15:0/0:0/PGE2)

C38H66O8 (650.4757)

DG(PGE2/0:0/i-15:0)

C38H66O8 (650.4757)

DG(i-15:0/PGD2/0:0)

C38H66O8 (650.4757)

DG(PGD2/i-15:0/0:0)

C38H66O8 (650.4757)

DG(i-15:0/0:0/PGD2)

C38H66O8 (650.4757)

DG(PGD2/0:0/i-15:0)

C38H66O8 (650.4757)

DG(15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/15:0/0:0)

C38H66O8 (650.4757)

DG(15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/15:0)

C38H66O8 (650.4757)

DG(a-15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-15:0/0:0)

C38H66O8 (650.4757)

DG(a-15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-15:0)

C38H66O8 (650.4757)

DG(i-15:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-15:0/0:0)

C38H66O8 (650.4757)

DG(i-15:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C38H66O8 (650.4757)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-15:0)

C38H66O8 (650.4757)

1-(Propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]-2-propanol

C36H62N2O8 (650.4506)

(9R)-9-[(hexadecyloxy)methyl]-2,2-dimethyl-6-oxido-6,11-dioxo-5,7,10-trioxa-2-azonia-6lambda(5)-phosphanonadecan-19-oate

C33H65NO9P- (650.4397)

N-[(3S,9R,10S)-9-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C37H54N4O6 (650.4043)

O-[1-O-Palmitoyl-2-O-(9-oxononanoyl)-L-glycero-3-phospho]choline

C33H65NO9P+ (650.4397)

[O-(1-O-Hexadecanoyl-2-O-decanoyl-L-glycero-3-phospho)choline]anion

C34H69NO8P+ (650.4761)

2-[hydroxy-[(2R)-3-octadecanoyloxy-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[[3-hexadecanoyloxy-2-[(E)-5-hydroxy-8-oxooct-6-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H61NO10P+ (650.4033)

O-(1-O-Decanoyl-2-O-palmitoyl-L-glycero-3-phospho)choline

C34H69NO8P+ (650.4761)

O-(1-O,2-O-Bistridecanoyl-L-glycero-3-phospho)choline

C34H69NO8P+ (650.4761)

NAGlySer 16:2/16:0

C37H66N2O7 (650.487)

NAGlySer 16:1/16:1

C37H66N2O7 (650.487)

NAGlySer 14:1/18:1

C37H66N2O7 (650.487)

NAGlySer 14:0/18:2

C37H66N2O7 (650.487)

NAGlySer 22:2/10:0

C37H66N2O7 (650.487)

NAGlySer 13:1/19:1

C37H66N2O7 (650.487)

NAGlySer 11:0/21:2

C37H66N2O7 (650.487)

NAGlySer 13:0/19:2

C37H66N2O7 (650.487)

NAGlySer 15:1/17:1

C37H66N2O7 (650.487)

NAGlySer 12:0/20:2

C37H66N2O7 (650.487)

NAGlySer 20:2/12:0

C37H66N2O7 (650.487)

NAGlySer 17:2/15:0

C37H66N2O7 (650.487)

NAGlySer 18:2/14:0

C37H66N2O7 (650.487)

NAGlySer 16:0/16:2

C37H66N2O7 (650.487)

NAGlySer 17:1/15:1

C37H66N2O7 (650.487)

NAGlySer 10:0/22:2

C37H66N2O7 (650.487)

NAGlySer 21:2/11:0

C37H66N2O7 (650.487)

NAGlySer 19:2/13:0

C37H66N2O7 (650.487)

NAGlySer 15:0/17:2

C37H66N2O7 (650.487)

NAGlySer 19:1/13:1

C37H66N2O7 (650.487)

NAGlySer 18:1/14:1

C37H66N2O7 (650.487)

Mgdg O-8:0_20:5

C37H62O9 (650.4394)

Mgdg O-24:5_4:0

C37H62O9 (650.4394)

Mgdg O-26:5_2:0

C37H62O9 (650.4394)

Mgdg O-22:5_6:0

C37H62O9 (650.4394)

Mgdg O-20:5_8:0

C37H62O9 (650.4394)

Mgdg O-10:0_18:5

C37H62O9 (650.4394)

Mgdg O-18:5_10:0

C37H62O9 (650.4394)

PE-Cer 18:2;2O/16:4

C36H63N2O6P (650.4424)

PE-Cer 14:1;2O/20:5

C36H63N2O6P (650.4424)

PE-Cer 14:2;2O/20:4

C36H63N2O6P (650.4424)

PE-Cer 16:1;2O/18:5

C36H63N2O6P (650.4424)

PE-Cer 12:1;2O/22:5

C36H63N2O6P (650.4424)

PE-Cer 12:0;2O/22:6

C36H63N2O6P (650.4424)

PE-Cer 14:3;2O/20:3

C36H63N2O6P (650.4424)

PE-Cer 18:3;2O/16:3

C36H63N2O6P (650.4424)

PE-Cer 16:3;2O/18:3

C36H63N2O6P (650.4424)

PE-Cer 16:2;2O/18:4

C36H63N2O6P (650.4424)

PE-Cer 12:2;2O/22:4

C36H63N2O6P (650.4424)

[(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H63N2O6P (650.4424)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] decanoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (Z)-heptadec-9-enoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (Z)-tridec-9-enoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (Z)-hexadec-9-enoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] undecanoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (Z)-tetradec-9-enoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] tetradecanoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] dodecanoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (Z)-pentadec-9-enoate

C34H67O9P (650.4522)

[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-octadec-9-enoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] tridecanoate

C34H67O9P (650.4522)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] pentadecanoate

C34H67O9P (650.4522)

4-[12-hydroxy-10,13-dimethyl-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C42H66O5 (650.491)

[(4E,8E,12E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H63N2O6P (650.4424)

[(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H63N2O6P (650.4424)

[(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H63N2O6P (650.4424)

[(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H63N2O6P (650.4424)

[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H63N2O6P (650.4424)

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C42H66O5 (650.491)

[1-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C42H66O5 (650.491)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C36H58O10 (650.403)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C36H58O10 (650.403)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C36H58O10 (650.403)

[2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H63N2O6P (650.4424)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-icos-11-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-docos-13-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-octadec-9-enoate

C33H63O10P (650.4159)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-henicos-11-enoate

C33H63O10P (650.4159)

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-heptadec-9-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] tetradecanoate

C33H63O10P (650.4159)

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-pentadec-9-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-octadec-9-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-docos-13-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-icos-11-enoate

C33H63O10P (650.4159)

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C33H63O10P (650.4159)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tetradecanoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-tetradec-9-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-hexadec-9-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C33H63O10P (650.4159)

2-[[(2R)-3-dodecanoyloxy-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[2,3-Di(tridecanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[[(2R)-2-dodecanoyloxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[[(2S)-2-decanoyloxy-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[hydroxy-[(2S)-3-pentadecanoyloxy-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2,3-bis[[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy]propyl (7Z,9Z)-tetradeca-7,9-dienoate

C41H62O6 (650.4546)

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (5Z,8Z,11Z)-tetradeca-5,8,11-trienoate

C41H62O6 (650.4546)

(1-hydroxy-3-nonanoyloxypropan-2-yl) (6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoate

C42H66O5 (650.491)

2-[Hydroxy-(2-pentadecanoyloxy-3-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[(3-Dodecanoyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[(2-Heptadecanoyloxy-3-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[(3-Decanoyloxy-2-hexadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[Hydroxy-(2-octadecanoyloxy-3-octanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

[1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C36H58O10 (650.403)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-heptadec-9-enoate

C33H63O10P (650.4159)

[1-carboxy-3-[3-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C42H66O5 (650.491)

[1-carboxy-3-[2-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[1-carboxy-3-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[1-carboxy-3-[2-tetradecanoyloxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[1-carboxy-3-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[1-carboxy-3-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[1-carboxy-3-[3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-2-tridecanoyloxypropoxy]propyl]-trimethylazanium

C38H68NO7+ (650.4996)

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] (8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoate

C42H66O5 (650.491)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-hexadec-7-enoate

C33H63O10P (650.4159)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-tetradec-9-enoate

C33H63O10P (650.4159)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-tridecanoyloxypropyl] (E)-tetradec-9-enoate

C33H63O10P (650.4159)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-heptadec-9-enoate

C33H63O10P (650.4159)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-hexadec-9-enoate

C33H63O10P (650.4159)

[1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C36H58O10 (650.403)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoate

C42H66O5 (650.491)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] (E)-pentadec-9-enoate

C33H63O10P (650.4159)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-9-enoate

C33H63O10P (650.4159)

2-[hydroxy-[(2R)-2-pentadecanoyloxy-3-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-7-enoate

C33H63O10P (650.4159)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

C33H63O10P (650.4159)

[(2S)-1-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C42H66O5 (650.491)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (14E,17E,20E)-tricosa-14,17,20-trienoate

C42H66O5 (650.491)

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoate

C42H66O5 (650.491)

2-[(3-Acetyloxy-2-tetracosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[Hydroxy-(3-propanoyloxy-2-tricosanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[(3-Heptanoyloxy-2-nonadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[(3-Butanoyloxy-2-docosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[(2-Henicosanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[(3-Hexanoyloxy-2-icosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO8P+ (650.4761)

2-[hydroxy-[2-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C36H61NO7P+ (650.4185)

2-[carboxy-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-undecanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C37H64NO8+ (650.4632)

2-[[2-acetyloxy-3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H61NO7P+ (650.4185)

2-[carboxy-[3-nonanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C37H64NO8+ (650.4632)

2alpha,3beta,23alpha-trihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranoside

C36H58O10 (650.403)

A triterpenoid saponin that is the carboxylic ester obtained by the formal condensation of the carboxy group of asiatic acid with beta,23alpha-trihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranose. It has been isolated from Juglans sinensis.

phosphatidylserine 26:0(1-)

C32H61NO10P (650.4033)

A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 26 carbons in total and 0 double bonds.

2alpha,3beta,23-trihydroxyolean-12-en-28-oic acid 28-O-beta-D-glucopynoside

C36H58O10 (650.403)

A triterpenoid saponin that is the carboxylic ester obtained by the formal condensation of the carboxy group of arjunolic acid with beta-D-glucopyranose. It has been isolated from Juglans sinensis.

LPG(28:1)

C34H67O9P (650.4522)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 21:7/O-23:7

C44H58O4 (650.4335)

FAHFA 22:7/O-22:7

C44H58O4 (650.4335)

FAHFA 23:7/O-21:7

C44H58O4 (650.4335)

DG 17:2_22:6

C42H66O5 (650.491)

MGDG O-27:6;O

C36H58O10 (650.403)

MGDG O-28:5

C37H62O9 (650.4394)

MGMG 28:5

C37H62O9 (650.4394)

MGGA 27:5

C36H58O10 (650.403)

PA O-14:1/20:5

C37H63O7P (650.4311)

PA O-16:2/18:4

C37H63O7P (650.4311)

PA O-18:0/12:2;O3

C33H63O10P (650.4159)

PA O-30:2;O3

C33H63O10P (650.4159)

PA O-34:6

C37H63O7P (650.4311)

PA P-14:0/20:5

C37H63O7P (650.4311)

PA P-14:0/20:5 or PA O-14:1/20:5

C37H63O7P (650.4311)

PA P-16:1/18:4

C37H63O7P (650.4311)

PA P-16:1/18:4 or PA O-16:2/18:4

C37H63O7P (650.4311)

PA P-34:5

C37H63O7P (650.4311)

PA P-34:5 or PA O-34:6

C37H63O7P (650.4311)

PA 22:0/8:1;O2

C33H63O10P (650.4159)

PA 30:1;O2

C33H63O10P (650.4159)

PG O-14:0/14:1

C34H67O9P (650.4522)

PG O-14:1/14:0

C34H67O9P (650.4522)

PG O-16:0/11:2;O

C33H63O10P (650.4159)

PG O-16:1/12:0

C34H67O9P (650.4522)

PG O-18:1/10:0

C34H67O9P (650.4522)

PG O-27:2;O

C33H63O10P (650.4159)

PG P-14:0/14:0

C34H67O9P (650.4522)

PG P-14:0/14:0 or PG O-14:1/14:0

C34H67O9P (650.4522)

PG P-16:0/12:0

C34H67O9P (650.4522)

PG P-16:0/12:0 or PG O-16:1/12:0

C34H67O9P (650.4522)

PG P-18:0/10:0

C34H67O9P (650.4522)

PG P-18:0/10:0 or PG O-18:1/10:0

C34H67O9P (650.4522)

PG P-18:0/9:1;O

C33H63O10P (650.4159)

PG P-28:0

C34H67O9P (650.4522)

PG P-28:0 or PG O-28:1

C34H67O9P (650.4522)

PG 10:0_17:1

C33H63O10P (650.4159)

PG 11:0_16:1

C33H63O10P (650.4159)

PG 12:0_15:1

C33H63O10P (650.4159)

PG 13:0_14:1

C33H63O10P (650.4159)

PG 23:0/4:1

C33H63O10P (650.4159)

LPEth 32:6

C37H63O7P (650.4311)

LPM 33:6

C37H63O7P (650.4311)

PEth 29:0;O

C34H67O9P (650.4522)

PM 30:0;O

C34H67O9P (650.4522)

CerPE 14:1;O2/20:5

C36H63N2O6P (650.4424)

CerPE 14:2;O2/20:4

C36H63N2O6P (650.4424)

CerPE 16:2;O2/18:4

C36H63N2O6P (650.4424)

CerPE 34:6;O2

C36H63N2O6P (650.4424)

DCAE 18:4

C42H66O5 (650.491)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r,4as,4bs,6as,7r,8s,10as,10br)-8-hydroxy-2-[(3r,4s)-4-hydroxy-3-methylpentyl]-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

3-[(3s,3as,4r,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C37H62O9 (650.4394)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

2'-[3-(2-hydroxy-4-methylpent-3-en-1-yl)-3-methyloxiran-2-yl]-4'b,8',8',10'a-tetramethyl-7'-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrospiro[oxolane-3,1'-phenanthren]-5-one

C36H58O10 (650.403)

3-[3-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C37H62O9 (650.4394)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2's,3s,4'ar,4'br,7's,8'ar,10'ar)-2'-[(2r,3s)-3-[(2r)-2-hydroxy-4-methylpent-3-en-1-yl]-3-methyloxiran-2-yl]-4'b,8',8',10'a-tetramethyl-7'-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrospiro[oxolane-3,1'-phenanthren]-5-one

C36H58O10 (650.403)

2-{[2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H58O10 (650.403)

(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboperoxoate

C36H58O10 (650.403)

(2r,3r,4s,5s,6r)-2-{[(4s,5s,6s)-6-[(1r,3as,3br,4s,7s,9as,9bs,11ar)-7-hydroxy-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-hydroxy-2-methylhept-2-en-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O9 (650.4394)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C36H58O10 (650.403)

20-epi-16'-decarbomethoxy 19,20-connoduramine

C41H54N4O3 (650.4196)

{"Ingredient_id": "HBIN003397","Ingredient_name": "20-epi-16'-decarbomethoxy 19,20-connoduramine","Alias": "NA","Ingredient_formula": "C41H54N4O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

20-epi-16'-decarbomethoxy-conoduramine

C41H54N4O3 (650.4196)

{"Ingredient_id": "HBIN003398","Ingredient_name": "20-epi-16'-decarbomethoxy-conoduramine","Alias": "NA","Ingredient_formula": "C41H54N4O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6884","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

21-o-β-d-glucopyranosyl-3β,21α,30-trihydroxy-olean-13(18)-en-24-oicacid

C36H58O10 (650.403)

{"Ingredient_id": "HBIN003588","Ingredient_name": "21-o-\u03b2-d-glucopyranosyl-3\u03b2,21\u03b1,30-trihydroxy-olean-13(18)-en-24-oicacid","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC12CCC3(C(=C1CC(C(C2)OC4C(C(C(C(O4)CO)O)O)O)(C)CO)CCC5C3(CCC6C5(CCC(C6(C)C(=O)O)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8744","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2,3,19-trihydroxy-12-ursen-28-oic acid; (2α,3β,19α)-form,28-o-beta-d-galactopyranosyl ester

C36H58O10 (650.403)

{"Ingredient_id": "HBIN003811","Ingredient_name": "2,3,19-trihydroxy-12-ursen-28-oic acid; (2\u03b1,3\u03b2,19\u03b1)-form,28-o-beta-d-galactopyranosyl ester","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "NA","Ingredient_weight": "650.84","OB_score": "NA","CAS_id": "146356-82-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9010","PubChem_id": "NA","DrugBank_id": "NA"}

2,3,24-trihydroxy-12-oleanen-28-oic acid; (2α,3α)-form,28-o-beta-d-glucopyranosyl ester

C36H58O10 (650.403)

{"Ingredient_id": "HBIN003825","Ingredient_name": "2,3,24-trihydroxy-12-oleanen-28-oic acid; (2\u03b1,3\u03b1)-form,28-o-beta-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "NA","Ingredient_weight": "650.84","OB_score": "NA","CAS_id": "274673-56-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9000","PubChem_id": "NA","DrugBank_id": "NA"}

28-O-β-D-xylopyranosyl-(1 → 3 )-O-α-L-rhamnopyranosyl-(1 → 2)-β-D-glucopyranosyl(1→6 )-β-D-glucopyranoside arjunolic acid

C36H58O10 (650.403)

{"Ingredient_id": "HBIN005081","Ingredient_name": "28-O-\u03b2-D-xylopyranosyl-(1 \u2192 3 )-O-\u03b1-L-rhamnopyranosyl-(1 \u2192 2)-\u03b2-D-glucopyranosyl(1\u21926 )-\u03b2-D-glucopyranoside arjunolic acid","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39946","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2α,3α,24-trihydroxyurs-12-en-28-oicacid-28-o-β-d-glucopyranosyl ester

C36H58O10 (650.403)

{"Ingredient_id": "HBIN005177","Ingredient_name": "2\u03b1,3\u03b1,24-trihydroxyurs-12-en-28-oicacid-28-o-\u03b2-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21849","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2α,3β,19α- trihydroxy ursolic acid

C36H58O10 (650.403)

{"Ingredient_id": "HBIN005199","Ingredient_name": "2\u03b1,3\u03b2,19\u03b1- trihydroxy ursolic acid","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42491","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

arjunicacid-28-o-glucoside

C36H58O10 (650.403)

{"Ingredient_id": "HBIN016849","Ingredient_name": "arjunicacid-28-o-glucoside","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14382","TCMID_id": "1735","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(3e,5e,7z,9z,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(1s)-1-[(1s,3as,3br,7s,9ar,9bs,11ar)-7-{[(2r,4r,5r,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl acetate

C36H58O10 (650.403)

(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

3-hydroxy-11-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicene-4-carboxylic acid

C36H58O10 (650.403)

6-hydroxy-15-(5-hydroxy-6-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-4,18-dione

C36H58O10 (650.403)

(3e,5z,7e,9z,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 9,10-dihydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(3e,5e,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(4r,4as,5r,6ar,6br,8ar,10r,11r,12as,14ar,14bs)-5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-b]pyran-2-one

C36H58O10 (650.403)

9-hydroxy-2,4a,7,7,10a,12a-hexamethyl-2-(3-methylbutan-2-yl)-3-oxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4b,5,6,6a,8,9,10,12-decahydrochrysene-1-carboxylic acid

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6ar,6br,8as,10r,11r,12ar,12bs,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,2r,4as,6as,6br,8ar,9s,10s,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C36H58O10 (650.403)

2-hydroxy-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

[(1s,4r,9r,10r,13r,14r)-14-hydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl (1s,4s,6r,9s,10r,13r,14r)-6-(acetyloxy)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate

C42H66O5 (650.491)

(5e,7e,9e,11z,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8r,8ar,9r,10s,12ar,12br,14bs)-8,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(5r)-5-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-5,9,12-trimethyl-15-[(6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-6,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,8,11(16),12,14-heptaene-8,14-diol

C44H58O4 (650.4335)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4as,4br,6as,8s,9r,10as,10br)-8,9-dihydroxy-2-[(3r,4s)-4-hydroxy-3-methylpentyl]-4a,4b,7,7,10a-pentamethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

(1s,3r,6s,8r,11s,12s,14s,15r,16r)-14-hydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-one

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,2r,4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C36H58O10 (650.403)

[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14br)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

3-[(3r,3ar,4r,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C37H62O9 (650.4394)

(3s,4ar,6as,6br,8as,9r,10s,12ar,12br,14br)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(5e,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(1r,3s,6r,8s,11s,12s,15r,16r)-6-hydroxy-15-[(2r,5s)-5-hydroxy-6-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-4,18-dione

C36H58O10 (650.403)

10-hydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C36H58O10 (650.403)

(2r)-2-[(1r,2r,3as,3br,7r,8r,9ar,9bs,11ar)-2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-6-methylhept-5-en-3-one

C36H58O10 (650.403)

(5r)-5-{5-[(2r,5s)-5-[(4s,7r)-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-1,3-dioxepan-4-yl]oxolan-2-yl]pentyl}-3-(2-oxopropyl)oxolan-2-one

C38H66O8 (650.4757)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,3as,5ar,5br,7r,7ar,9r,10r,11ar,11br,13ar,13br)-7,9,10-trihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

6-{2-[(1e)-2-(4-{hydroxy[2-(6-oxooxan-2-yl)cyclopropyl]methyl}-5-[(3e,6e)-1-hydroxynona-3,6-dien-1-yl]-2-[(2e,5e)-octa-2,5-dien-1-yl]oxolan-3-yl)ethenyl]cyclopropyl}oxan-2-one

C40H58O7 (650.4182)

(3s,4s,4ar,5r,6ar,6bs,8s,8as,10s,12as,14ar,14br)-5,8,10-trihydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carbaldehyde

C36H58O10 (650.403)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-{[(2r)-2,3-dihydroxypropoxy]methyl}oxane-3,4,5-triol

C38H66O8 (650.4757)

(4r,4ar,5r,6ar,6br,8as,10r,11r,12as,14as,14bs)-5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-c]pyran-1-one

C36H58O10 (650.403)

(6r)-6-[(1r,2s)-2-[(1e)-2-[(2r,3s,4r,5s)-4-[(r)-hydroxy[(1r,2r)-2-[(2r)-6-oxooxan-2-yl]cyclopropyl]methyl]-5-[(1s,3z,6z)-1-hydroxynona-3,6-dien-1-yl]-2-[(2z,5z)-octa-2,5-dien-1-yl]oxolan-3-yl]ethenyl]cyclopropyl]oxan-2-one

C40H58O7 (650.4182)

(3z,5z,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(3e,5e,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-32-isopropyl-15,31-dimethyl-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10s,12ar,12br,14br)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

2-(2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl)-2-hydroxy-6-methylhept-5-en-3-one

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-hydroxy-2,9-bis(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4as,4br,6as,7s,8r,10as,10br)-8-hydroxy-2-[(3r,4s)-4-hydroxy-3-methylpentyl]-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

(1r,2s,3as,3bs,7s,9ar,9br,11ar)-2-hydroxy-1-[(2s,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10s,12as,12br,14bs)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboperoxoate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r,4ar,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,9-bis(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4ar,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2r)-2-[(1r,2r,3as,3br,7r,8s,9as,9br,11ar)-2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-6-methylhept-5-en-3-one

C36H58O10 (650.403)

(4as,6as,6br,8ar,9r,10r,11s,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

8-hydroxy-16-[3-hydroxy-4-(6-isopropyl-2,4-dimethoxy-5-methyloxan-2-yl)pentan-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C37H62O9 (650.4394)

5,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(4as,6as,6br,8as,9r,10r,11s,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(2r,3r,4r,5s,6r)-2-{[(1r,3as,3br,4s,6s,7s,9as,9bs,11ar)-7-hydroxy-6-(hydroxymethyl)-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,9b,11a-tetramethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O9 (650.4394)

(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(4r,4as,5r,6ar,6br,8as,10s,11r,12as,14ar,14bs)-5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-b]pyran-2-one

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 8,9-dihydroxy-2-(4-hydroxy-3-methylpentyl)-4a,4b,7,7,10a-pentamethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

2-[(5-hydroxy-6-{7-hydroxy-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-en-4-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O9 (650.4394)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,10s,11s,12as,12br,14br)-10,11-dihydroxy-12a-(hydroxymethyl)-2,2,6a,6b,9,9-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

3-[(3s,3ar,4r,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C37H62O9 (650.4394)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,3as,5ar,5br,7ar,8s,9r,10r,11ar,11br,13ar,13br)-9,10-dihydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

5-(4,8-dimethylnona-3,7-dien-1-yl)-5,9,12-trimethyl-15-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-6,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,8,11(16),12,14-heptaene-8,14-diol

C44H58O4 (650.4335)

(3s,4r,4as,6ar,6bs,8as,10r,11s,14ar,14br)-3-hydroxy-11-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-10-{[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicene-4-carboxylic acid

C36H58O10 (650.403)

(1s,2r,4ar,4br,6ar,8r,9r,10as,12as)-9-hydroxy-2,4a,7,7,10a,12a-hexamethyl-2-[(2r)-3-methylbutan-2-yl]-3-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4b,5,6,6a,8,9,10,12-decahydrochrysene-1-carboxylic acid

C36H58O10 (650.403)

(4ar,5r,6as,6br,8ar,9r,10r,11s,12ar,12br,14bs)-5,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(4r,4ar,5r,6ar,6br,8ar,10r,11r,12as,14as,14bs)-5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-c]pyran-1-one

C36H58O10 (650.403)

5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-c]pyran-1-one

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10s,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2r,3r,4s,5s,6r)-2-{[(4s,5r,6s)-6-[(1r,3as,3br,4r,7s,9as,9bs,11ar)-7-hydroxy-4-methoxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-hydroxy-2-methylhept-2-en-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O9 (650.4394)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 8-hydroxy-2-(4-hydroxy-3-methylpentyl)-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 8,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-b]pyran-2-one

C36H58O10 (650.403)

(4as,6as,6br,8ar,9r,10r,11s,12ar,12br,14br)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

2-[(2,3-dihydroxypropoxy)methyl]-6-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C38H66O8 (650.4757)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(3e,5e,7e,9e,11z,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 7,9,10-trihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

(7r,8s,9s,15s,16r)-8-hydroxy-16-[(2s,3r,4s)-3-hydroxy-4-[(2r,4r,5s,6r)-6-isopropyl-2,4-dimethoxy-5-methyloxan-2-yl]pentan-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C37H62O9 (650.4394)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r,4as,4bs,6ar,8s,9r,10as,10br)-8,9-dihydroxy-2-[(3r,4s)-4-hydroxy-3-methylpentyl]-4a,4b,7,7,10a-pentamethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

{14-hydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl}methyl 6-(acetyloxy)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate

C42H66O5 (650.491)

(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8r,8ar,10r,11r,12ar,12br,14bs)-8,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,3as,5ar,5br,7ar,8s,9r,10r,11ar,11br,13ar,13bs)-9,10-dihydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

2-{[7-hydroxy-6-(hydroxymethyl)-1-(6-methoxy-6-methylhept-4-en-2-yl)-3a,6,9b,11a-tetramethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O9 (650.4394)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(5r)-5-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-5,9,12-trimethyl-15-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-6,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,8,11(16),12,14-heptaene-8,14-diol

C44H58O4 (650.4335)

(3s,9r)-3-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(1r,2s,3r,4ar,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C36H58O10 (650.403)

(3e,5e,7z,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,3as,5ar,5br,7r,7ar,9r,10r,11ar,11br,13ar,13bs)-7,9,10-trihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

6-{2-[2-(4-{hydroxy[2-(6-oxooxan-2-yl)cyclopropyl]methyl}-5-(1-hydroxynona-3,6-dien-1-yl)-2-(octa-2,5-dien-1-yl)oxolan-3-yl)ethenyl]cyclopropyl}oxan-2-one

C40H58O7 (650.4182)

5,8,10-trihydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carbaldehyde

C36H58O10 (650.403)

(2r,3r,4s,5r,6r)-2-{[(1s,2r,3s,4r,7r,9s,12r,14s,17r,18r,19r,21r,22s)-2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9s,10s,12ar,12br,14bs)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2r,3r,4s,5r,6r)-2-{[(3s,4r,4ar,6ar,6bs,8s,8as,12as,14r,14ar,14bs)-8-hydroxy-4,8a-bis(hydroxymethyl)-14-methoxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-methyloxane-3,4,5-triol

C37H62O9 (650.4394)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9s,10s,12ar,12br,14br)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,10s,11r,12ar,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(3z,5z,7z,9z,11z,29z)-14,16,18,20,22,24,26,28-octahydroxy-32-isopropyl-15,31-dimethyl-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

14-hydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-one

C36H58O10 (650.403)

(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(1s,2r,4ar,4br,6as,8r,9r,10as,12as)-9-hydroxy-2,4a,7,7,10a,12a-hexamethyl-2-[(2r)-3-methylbutan-2-yl]-3-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4b,5,6,6a,8,9,10,12-decahydrochrysene-1-carboxylic acid

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,8as,12ar,12br,14br)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)